Active Pharmaceutical Ingredient:
Beta-blocking agents, selective
- Esmolol hydrochloride is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.
- Esmolol hydrochloride is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia where, in the physician’s judgement the rapid heart rate requires specific intervention.
1 vial with 2500 mg powder for solution for infusion
Additional pharmaceutical formulations:
ESMOCARD® 100 mg/ 10 ml solution for injection (5 vials per pack)